We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
China disruption, consumer pressure and a reduced 2026 outlook weigh on the near-term recovery.
Kimberly-Clark Corporation (KMB - Free Report) offers investors a valuation-versus-execution trade-off. The stock trades below key historical and market benchmarks while the company continues to post volume-and-mix gains and margin improvement.
That discount is balanced by slower category growth, consumer pressure and disruption in China. The current setup supports patience rather than a clear-cut buying case.
KMB's Valuation Discount Strengthens the Bull Case
KMB trades at 14.75X forward 12-month earnings, below 18.28X for the industry, 16.81X for the Zacks Consumer Staples sector and 20.69X for the S&P 500. Its multiple is also below the one-year median of 14.63X, though above the one-year low of 12.52X.
Image Source: Zacks Investment Research
The discount gives investors a lower entry valuation relative to those benchmarks, but it does not erase execution risk. Consumer-staples peers Colgate-Palmolive Company (CL - Free Report) and Church & Dwight Co., Inc. (CHD - Free Report) provide useful comparison points for investors weighing KMB's valuation, growth profile and execution risks.
Kimberly-Clark's Volume-Mix Engine Is Holding
Kimberly-Clark delivered its 10th consecutive quarter of positive volume-plus-mix performance. In the first half of 2026, organic sales rose 1.2%, supported by 1.3% volume growth and a 0.4% mix benefit, partly offset by a 0.5% decline in net pricing.
North America has generated volume-plus-mix-led growth in eight of the past 10 quarters. Trailing 12-month share gains covered 70% of its North American sales base, giving the company a demand foundation as category growth moderates.
KMB's Productivity Is Protecting Margins
Gross productivity reached 6.4% in the second quarter of 2026. Adjusted gross margin expanded 190 basis points year over year to 38.8%.
Adjusted operating profit increased 6.2% to $757 million as productivity savings, one-time tariff refunds and favorable currency effects outweighed other pressures. That cost discipline is important because Kimberly-Clark continues to invest in product trial, brand support and supply-chain initiatives.
KMB's EPS Picture Shows Growth, but Estimates Stay Soft
Kimberly-Clark reported second-quarter 2026 adjusted earnings from continuing operations of $1.80 per share, up 10.4% year over year, but below the Zacks Consensus Estimate of $2.00. Adjusted earnings attributable to Kimberly-Clark were $2.12 per share, also up 10.4%, helped by higher adjusted operating profit and income from discontinued operations.
Kimberly-Clark Corporation Price, Consensus and EPS Surprise
For 2026, Kimberly-Clark expects adjusted EPS from continuing operations to grow at a high-single-digit rate on a constant-currency basis, including an approximately 30% increase in income from equity companies. However, adjusted EPS attributable to Kimberly-Clark is expected to decline at a low-single-digit rate, reflecting a more complicated earnings mix following portfolio changes.
China and Consumer Pressure Cloud KMB's Outlook
The China diaper disruption reduced consolidated organic sales growth by about 50 basis points and created an approximately 440-basis-point headwind to International Personal Care operating profit. Management expects the issue to continue affecting sales and profits in the near term.
North American weighted category growth slowed to 1.9% from 3.7% sequentially, while lower-income consumers remain pressured.
KMB's Financial Position Supports Its Transformation
Kimberly-Clark ended the quarter with $956 million in cash and cash equivalents and $6.474 billion in long-term debt. Cash provided by operations totaled $1.653 billion in the first six months of 2026.
Capital spending reached $776 million during the period, while dividends returned $843 million to shareholders. The cash generation gives Kimberly-Clark resources to fund investment while it advances portfolio and operational changes.
KMB's Ranking Picture Remains Incomplete
The bottom line is balanced. KMB's valuation discount, sustained volume-and-mix momentum and productivity gains support the case for holding the shares, but China disruption, softer category growth and a reduced 2026 outlook limit the near-term argument for aggressive buying.
KMB currently carries a Zacks Rank #3 (Hold), along with a Value Score of C, a Growth Score of C, a Momentum Score of F and a VGM Score of C. Rank #3 can support holding an existing position, while the middling Value, Growth and VGM Scores and weak Momentum Score do not add a strong style-based buying signal. Investors may prefer to wait for clearer evidence of sales normalization and steadier category trends. You can seethe complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
View the Zacks #1 Rank List
Image: Bigstock
Is KMB Worth Buying as Low Valuation Meets China and Growth Risks?
Key Takeaways
Kimberly-Clark Corporation (KMB - Free Report) offers investors a valuation-versus-execution trade-off. The stock trades below key historical and market benchmarks while the company continues to post volume-and-mix gains and margin improvement.
That discount is balanced by slower category growth, consumer pressure and disruption in China. The current setup supports patience rather than a clear-cut buying case.
KMB's Valuation Discount Strengthens the Bull Case
KMB trades at 14.75X forward 12-month earnings, below 18.28X for the industry, 16.81X for the Zacks Consumer Staples sector and 20.69X for the S&P 500. Its multiple is also below the one-year median of 14.63X, though above the one-year low of 12.52X.
Image Source: Zacks Investment Research
The discount gives investors a lower entry valuation relative to those benchmarks, but it does not erase execution risk. Consumer-staples peers Colgate-Palmolive Company (CL - Free Report) and Church & Dwight Co., Inc. (CHD - Free Report) provide useful comparison points for investors weighing KMB's valuation, growth profile and execution risks.
Kimberly-Clark's Volume-Mix Engine Is Holding
Kimberly-Clark delivered its 10th consecutive quarter of positive volume-plus-mix performance. In the first half of 2026, organic sales rose 1.2%, supported by 1.3% volume growth and a 0.4% mix benefit, partly offset by a 0.5% decline in net pricing.
North America has generated volume-plus-mix-led growth in eight of the past 10 quarters. Trailing 12-month share gains covered 70% of its North American sales base, giving the company a demand foundation as category growth moderates.
KMB's Productivity Is Protecting Margins
Gross productivity reached 6.4% in the second quarter of 2026. Adjusted gross margin expanded 190 basis points year over year to 38.8%.
Adjusted operating profit increased 6.2% to $757 million as productivity savings, one-time tariff refunds and favorable currency effects outweighed other pressures. That cost discipline is important because Kimberly-Clark continues to invest in product trial, brand support and supply-chain initiatives.
KMB's EPS Picture Shows Growth, but Estimates Stay Soft
Kimberly-Clark reported second-quarter 2026 adjusted earnings from continuing operations of $1.80 per share, up 10.4% year over year, but below the Zacks Consensus Estimate of $2.00. Adjusted earnings attributable to Kimberly-Clark were $2.12 per share, also up 10.4%, helped by higher adjusted operating profit and income from discontinued operations.
Kimberly-Clark Corporation Price, Consensus and EPS Surprise
Kimberly-Clark Corporation price-consensus-eps-surprise-chart | Kimberly-Clark Corporation Quote
For 2026, Kimberly-Clark expects adjusted EPS from continuing operations to grow at a high-single-digit rate on a constant-currency basis, including an approximately 30% increase in income from equity companies. However, adjusted EPS attributable to Kimberly-Clark is expected to decline at a low-single-digit rate, reflecting a more complicated earnings mix following portfolio changes.
China and Consumer Pressure Cloud KMB's Outlook
The China diaper disruption reduced consolidated organic sales growth by about 50 basis points and created an approximately 440-basis-point headwind to International Personal Care operating profit. Management expects the issue to continue affecting sales and profits in the near term.
North American weighted category growth slowed to 1.9% from 3.7% sequentially, while lower-income consumers remain pressured.
KMB's Financial Position Supports Its Transformation
Kimberly-Clark ended the quarter with $956 million in cash and cash equivalents and $6.474 billion in long-term debt. Cash provided by operations totaled $1.653 billion in the first six months of 2026.
Capital spending reached $776 million during the period, while dividends returned $843 million to shareholders. The cash generation gives Kimberly-Clark resources to fund investment while it advances portfolio and operational changes.
KMB's Ranking Picture Remains Incomplete
The bottom line is balanced. KMB's valuation discount, sustained volume-and-mix momentum and productivity gains support the case for holding the shares, but China disruption, softer category growth and a reduced 2026 outlook limit the near-term argument for aggressive buying.
KMB currently carries a Zacks Rank #3 (Hold), along with a Value Score of C, a Growth Score of C, a Momentum Score of F and a VGM Score of C. Rank #3 can support holding an existing position, while the middling Value, Growth and VGM Scores and weak Momentum Score do not add a strong style-based buying signal. Investors may prefer to wait for clearer evidence of sales normalization and steadier category trends. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.